Report Fraud About Us What We Do

Consumer News

Two Lots of Prescription Migraine Medication Relpax Recalled

Relpax, a prescription drug used to treat migraines in adults is being recalled, due to the possibility it could be contaminated with bacteria that could cause a life-threatening infection. Pfizer Inc. has issued a recall for two lots of Relpax, AR5407 and CD4565, saying they may contain these infection-causing microorganisms. 

In addition to these infections, people who take this medication may also experience gastrointestinal distress. Those with weak immune systems and some chronic illnesses may be at greater risk of having adverse reactions. 

The affected lots of Relpax were distributed across the nation from June to July of this year.

Patients that have the affected lots should return them to their pharmacy, or contact Stericycle Inc. the number 877-225-9750 to get instructions on how to return the product and collect reimbursement.

If you have questions or concerns about how this recall may affect you, call your physician.

Do you have additional information about this recall? Is there another recall you want us to cover? Tell us in the comments below. You can also contact us for more information! Feel free to shoot us an email to Outreach@ConsiderTheConsumer.com. You can also find us on TwitterFacebook, InstagramLinkedIn, or even connect with us directly on our website!

About the Author: Aisha K. Staggers is a writer, lecturer, political analyst and literary agent. She appears weekly for “Staggers’ State of Things” on the Dr. Vibe Show. Her work has been published by Paper Magazine, AfroPunk, The Spool, GREY Journal, MTV News, HuffPost, Blavity, Atlanta Blackstar, For Harriet, New York Review of Books and a host of other first-run publications and syndicated outlets. Find her on Twitter @AishaStaggers. For more of her work, check out her page here!

Interested in posts like these? Stay up to date with our newsletter!

No thoughts on “Two Lots of Prescription Migraine Medication Relpax Recalled” yet. Be the first to speak your mind!

Leave a Reply